References
- Fenske, D. B.; MacLachlan, I.; Cullis, P. R. Methods Enzymol. 2002, 346, 36. https://doi.org/10.1016/S0076-6879(02)46048-X
- McCormick, F. Nat. Rev. Cancer 2001, 1, 130. https://doi.org/10.1038/35101008
- Woodle, M. C.; Lasic, D. D. Biophys. Acta. 1992, 1113, 171. https://doi.org/10.1016/0304-4157(92)90038-C
- Pun, S. H.; Davis, M. E. Bioconjugate Chem. 2002, 9, 731.
- Allen, T. M.; Hansen, C.; Martin, F.; Redemann, C.; Yau-Young, A. Biochim. Biophys. Acta. 1991, 1066, 29. https://doi.org/10.1016/0005-2736(91)90246-5
- Ogris, M.; Brunner, P.; Schuller, S.; Kircheis, R.; Wagner, E. Gene Ther. 1999, 6, 595. https://doi.org/10.1038/sj.gt.3300900
- Audouy, S.; de Leij, L.; Hoekstra, D.; Molema, G. Pharm. Res. 2002, 19, 1599. https://doi.org/10.1023/A:1020989709019
- Bendas, G. BioDrugs 2001, 15, 215. https://doi.org/10.2165/00063030-200115040-00002
- Sheer, D. G.; Schlom, J.; Cooper, H. L. Cancer Res. 1988, 48, 6811.
- Maruyama, K.; Takahashi, N.; TAGawa, T.; Nagaike, K.; Iwatsuru, M. FEBS. Letters 1997, 413, 177. https://doi.org/10.1016/S0014-5793(97)00905-8
- Mamot, C.; Drummond, D. C.; Nobel, C. O.; Kallab, V.; Guo, Z.; Hong, K. Cancer Res. 2005, 65, 11631. https://doi.org/10.1158/0008-5472.CAN-05-1093
- Maruyama, K. Biosci. Rep. 2002, 22, 251. https://doi.org/10.1023/A:1020138622686
- Kashmiri, S. V. S.; Shu, L.; Padlan, E. A.; Milenic, D. E.; Schlom, J.; Hand, P. H. Hybridoma 1995, 14, 461. https://doi.org/10.1089/hyb.1995.14.461
- Kim, K. S.; Park, Y. S. Oncol. Res. 2005, 15, 343. https://doi.org/10.3727/096504005776449707
- Song, Y. K.; Liu, F.; Liu, D. Hum. Gene Ther. 1997, 8, 1585. https://doi.org/10.1089/hum.1997.8.13-1585
- Shi, N.; Pardridge, W. M. Proc. Natl. Acad. Sci. USA 2000, 97, 7567. https://doi.org/10.1073/pnas.130187497
- Kim, K. S.; Lee, Y. K.; Kim, J. S.; Koo, K. H.; Hong, H. J.; Park, Y. S. Cancer Gene. Ther. 2008, 15, 331. https://doi.org/10.1038/cgt.2008.11
- Xu, L.; Tang, W. H.; Huang, C. C.; Alexander, W.; Xiang, L. M.; Pirollo, K. F.; Rait, A.; Chang, E. H. Mol. Med. 2001, 7, 726.
Cited by
- Antiviral Efficacy of a Short PNA Targeting microRNA-122 Using Galactosylated Cationic Liposome as a Carrier for the Delivery of the PNA-DNA Hybrid to Hepatocytes vol.34, pp.3, 2013, https://doi.org/10.5012/bkcs.2013.34.3.735
- Engineering liposomal nanoparticles for targeted gene therapy vol.24, pp.8, 2017, https://doi.org/10.1038/gt.2017.41
- Targeted and modular architectural polymers employing bioorthogonal chemistry for quantitative therapeutic delivery vol.11, pp.12, 2012, https://doi.org/10.1039/d0sc00078g